BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 12557178)

  • 21. Hepatitis B virus resistance to antivirals: clinical implications and management.
    Zoulim F
    J Hepatol; 2003; 39 Suppl 1():S133-8. PubMed ID: 14708691
    [No Abstract]   [Full Text] [Related]  

  • 22. Successful long-term control with lamivudine against reactivated hepatitis B infection following intensive chemotherapy and autologous peripheral blood stem cell transplantation in non-Hodgkin's lymphoma: experience of 2 cases.
    Nakagawa M; Simizu Y; Suemura M; Sato B
    Am J Hematol; 2002 May; 70(1):60-3. PubMed ID: 11994984
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Lamivudine resistance impedes hepatitis B therapy].
    Eggers HJ
    Fortschr Med; 1997 Apr; 115(12):5. PubMed ID: 9235306
    [No Abstract]   [Full Text] [Related]  

  • 24. [Current treatment of hepatitis B].
    Suárez García E; Romero Gómez M; Grande Santamaría L
    Gastroenterol Hepatol; 2001 Feb; 24 Suppl 1():35-50. PubMed ID: 11279893
    [No Abstract]   [Full Text] [Related]  

  • 25. Adefovir dipivoxil to prevent exacerbation of lamivudine-resistant hepatitis B infection during chemotherapy for non-Hodgkin's lymphoma.
    Enomoto M; Nishiguchi S; Seki S; Yamane T; Hino M
    Am J Gastroenterol; 2004 Aug; 99(8):1619-20. PubMed ID: 15307884
    [No Abstract]   [Full Text] [Related]  

  • 26. [Effective treatment with Lamivudine of patients with reactivation of hepatitis B following chemotherapy administration].
    Shtalrid M; Haran M; Klepfish A; Lurie Y; Malnick S
    Harefuah; 2001 Dec; 140(12):1159-62, 1230, 1229. PubMed ID: 11789300
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lamivudine for the prevention of hepatitis B virus reactivation during autologous stem cell transplantation. A case report.
    Silvestri F; Sperotto A; Ermacora A; Fanin R; Damiani D; Baccarani M
    Haematologica; 2000 Mar; 85(3):327-9. PubMed ID: 10702831
    [No Abstract]   [Full Text] [Related]  

  • 28. Controversies about the treatment of hepatitis B (lamivudine, interferon, a combination or more?).
    Desai HG; Chowdhury A
    Trop Gastroenterol; 2003; 24(3):157-60. PubMed ID: 14978995
    [No Abstract]   [Full Text] [Related]  

  • 29. [Treatment of liver cirrhosis due to hepatitis B with lamivudine].
    Castellano G; Fernández I; Jiménez C; Solís Herruzo JA
    Gastroenterol Hepatol; 1999 Oct; 22(8):433-4. PubMed ID: 10592680
    [No Abstract]   [Full Text] [Related]  

  • 30. Tenofovir helps experienced patients.
    AIDS Patient Care STDS; 2002 Mar; 16(3):136. PubMed ID: 11951839
    [No Abstract]   [Full Text] [Related]  

  • 31. More uses for tenofovir?
    AIDS Treat News; 2001 Jan; (377):4. PubMed ID: 11862808
    [No Abstract]   [Full Text] [Related]  

  • 32. Use of tenofovir.
    AIDS Patient Care STDS; 2002 Jan; 16(1):52. PubMed ID: 11892609
    [No Abstract]   [Full Text] [Related]  

  • 33. Food and Drug Administration approves lamivudine for hepatitis B.
    Front Med Biol Eng; 1999; 9(1):95. PubMed ID: 10354913
    [No Abstract]   [Full Text] [Related]  

  • 34. Treatment of chronic hepatitis B virus infection in patients co-infected with human immunodeficiency virus.
    Benhamou Y; Poynard T
    J Hepatol; 2003; 39 Suppl 1():S194-9. PubMed ID: 14708703
    [No Abstract]   [Full Text] [Related]  

  • 35. New strategies for treating AIDS.
    Sandstrom PA; Folks TM
    Bioessays; 1996 May; 18(5):343-6. PubMed ID: 8639156
    [TBL] [Abstract][Full Text] [Related]  

  • 36. FDA approves tenofovir.
    AIDS Patient Care STDS; 2002 Jan; 16(1):52. PubMed ID: 11892608
    [No Abstract]   [Full Text] [Related]  

  • 37. Promising results for tenofovir.
    AIDS Patient Care STDS; 2000 Jul; 14(7):396. PubMed ID: 10935058
    [No Abstract]   [Full Text] [Related]  

  • 38. Rescue therapy for drug resistant hepatitis B: another argument for combination chemotherapy?
    Shaw T; Bowden S; Locarnini S
    Gastroenterology; 2004 Jan; 126(1):343-7. PubMed ID: 14699512
    [No Abstract]   [Full Text] [Related]  

  • 39. Tenofovir DF trial announced by Gilead.
    Eagan L
    Posit Living; 2000 Jul; 9(6):22, 54. PubMed ID: 12492018
    [No Abstract]   [Full Text] [Related]  

  • 40. Lamivudine therapy in renal allograft recipients with hepatitis B virus infection.
    Tsang WK; Tong KL; Chan HW
    Transplant Proc; 2003 Feb; 35(1):278-9. PubMed ID: 12591398
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.